“This appointment reflects our commitment to strategic development and expansion within the gene therapy market. W...
The new generation of tubes "Eppendorf Tubes® BioBased" is made from 90 % "bio-circular", renewable-based feedstook ...
The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has agreed to acquire 100...
The Coalition for Epidemic Preparedness Innovations (CEPI), Norway has announced funding of up to $375,000 to the UK Med...
Thi Hoang Duong Nguyen, born in 1987, receives the 20,000 euro award for her pioneering work on the structure and functi...
In collaboration with a Japanese firm SBX Corporation, a Swiss-based firm Philip Morris International has deve...
Senator h.c. Udo J. Vetter, Chairman of the Advisory Board and member of the owner family (second from left) along with ...
Pharmapack Europe recognizes excellence and innovation from exhibitors across connected devices, sustainability, supply ...
UK-based Croda has announced that its Health Care division will now become Croda Pharma, bringing its core speciality ex...
QIAGEN has signed agreements to acquire a 96% majority ownership stake in BLIRT SA, a manufacturer of recombinant enzyme...
Exothera, a CDMO specialised in the development and manufacture of viral vectors for vaccines and gene therapies, receiv...
Exothera was founded in 2020 to help tackle two of the most critical challenges manufacturers face in bringing adva...
Wars are complex and lead to the breakdown of society, infrastructure damage, and economic impacts. Although it’s ...
Polyplus, a leading provider of upstream process solutions for advanced biologic and cell and gene therapy production fr...
Eppendorf recently expanded its centrifuge offering with the acquisition of the centrifugation business of the Japa...
Eppendorf and the journal Science are now accepting applications for the 2022 Eppendorf & Science Prize for ...
InSilicoTrials, a leader in simulation software solutions for healthcare, has appointed Mario Torchia as Vice President ...
The life science group Sartorius is expanding its bioanalytics portfolio by acquiring a majority stake in ALS Automated ...
